微电生理股价涨5.45%，华宝基金旗下1只基金位居十大流通股东，持有403.74万股浮盈赚取500.64万元

Company Overview - Microelectrophysiology, a company based in Shanghai, specializes in innovative medical devices for electrophysiological intervention and ablation therapy, with a total market capitalization of 11.285 billion yuan as of November 20 [1] - The company was established on August 31, 2010, and went public on August 31, 2022 [1] - Revenue composition includes catheter products (71.77%), other products (20.22%), equipment (7.24%), and leasing services (0.77%) [1] Stock Performance - On November 20, the stock price increased by 5.45%, reaching 23.98 yuan per share, with a trading volume of 63.1665 million yuan and a turnover rate of 2.19% [1] Shareholder Information - Huabao Fund's Huabao Zhongzheng Medical ETF (512170) is among the top ten circulating shareholders, having reduced its holdings by 574,900 shares in the third quarter, now holding 4.0374 million shares, which is 3.23% of the circulating shares [2] - The ETF has a current scale of 26.404 billion yuan and has achieved a year-to-date return of 8.3% [2] Fund Management - The fund manager of Huabao Zhongzheng Medical ETF is Hu Jie, who has a tenure of 13 years and 39 days, managing assets totaling 100.204 billion yuan [3] - The best fund return during Hu Jie's tenure is 183.07%, while the worst return is -98.01% [3]